Pivikto alpelisib

BYL719, albelixir, aborib, aperisib , apelix, QCR-1, BYL-719, NVP-BYL-719, Pivikto

Piqray (alpelisib) is a prescription medicine used in men and postmenopausal women with HR-positive, HER2-negative breast cancer that is advanced or has spread to other parts of the body (metastatic).

Piqray is only used if your cancer has a specific genetic marker (an abnormal "PIK3CA" gene). Your doctor will test you for this gene.

Piqray is used in combination with fulvestrant (Faslodex).